An EpiPen alternative is about to return to your local pharmacy
(By Ed Silverman for ST A T) T he controversial EpiPen device is about to get still more competition. A
Read More
Part D/Prescription Drugs
How To Enroll In Medicare And Avoid Costly Mistakes
(By Judith Graham for Kaiser Health News) Your 65th birthday is coming up. Soon, you think, the government will send
Read MoreSimplified Study Aims To Quickly Test A Long-Shot ALS Treatment
(By Richard Harris for NPR) Researchers have launched an innovative medical experiment that’s designed to provide quick answers while meeting
Read MoreGlaxoSmithKline Files for Regulatory Approval for Shingrix
GlaxoSmithKline has filed for U.S. regulatory approval for their shingles vaccine Shingrix which has shown greater protection among older recipients
Read MoreFifty Countries without Adequate Supplies of the Polio Vaccine
With polio on the brink of global eradication, Jon Abramson of World Health Organization stated there are only two manufacturers
Read MoreSanders seeks Ariad data on cancer drug price hikes
(By Ed Silverman for ST A T) C all it Bernie Sanders vs. Ariad Pharmaceuticals, Act Two. The Vermont senator
Read MoreGilead asks FDA to expand exclusivity for a key HIV drug
(By Ed Silverman for ST A T) n the latest development in a heated battle between Gilead Sciences and the
Read MoreFDA official warns other drug makers not to copy Sarepta
(By Ed Silverman for ST A T) A ny company that plans to mimic the approach taken by Sarepta Therapeutics
Read MoreSmall Savings For Drugs Made To Mimic Biotech Blockbusters
(By Richard Harris for NPR) Generic drugs generally cost 80 percent less than brand-name drugs, so hopes were high when
Read MoreWest Virginia Grapples With High Drug Costs
(By Kara Lofton, West Virginia Public Broadcasting published by Kaiser Health News) Skyrocketing prices for essential medicines, like the EpiPen,
Read More